Charles Semba
Directeur/Membre du Conseil chez DIAMEDICA THERAPEUTICS INC.
Fortune : 204 320 $ au 30/06/2024
Profil
Charles P.
Semba is currently an Independent Director at DiaMedica Therapeutics, Inc., a Professor at Stanford University, a Member of The American College of Radiology, a Member of the American College of Cardiology Foundation, and the Chief Medical Officer at Eluminex Biosciences Ltd.
He previously held positions as Senior Director-Tissue Growth & Repair at Genentech, Inc., Chief Medical Officer at SARcode Bioscience, Inc., Chief Medical Officer at ForSight VISION5, Inc., Chief Medical Officer at Graybug Vision, Inc., President at American Heart Association, Inc., and Associate Professor at Stanford University School of Medicine.
Semba received his undergraduate degree from Carleton College and his doctorate from the University of Minnesota.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2024 | 39 318 ( inf% ) | 115 988 $ | 30/06/2024 | |
| 01/06/2024 | 29 943 ( 0,08% ) | 88 332 $ | 30/06/2024 |
Postes actifs de Charles Semba
| Sociétés | Poste | Début |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Directeur/Membre du Conseil | 15/07/2021 |
| Stanford University | Corporate Officer/Principal | - |
The American College of Radiology
 The American College of Radiology Miscellaneous Commercial ServicesCommercial Services The American College of Radiology is a national organization serving radiologists, radiation oncologists, interventional radiologists, and medical physicists with programs focusing on the practice of radiology and the delivery of comprehensive health care services. ACR devotes its programs to make imaging safe, effective, and accessible. The college publishes the journal of the American College of Radiology and the ACR bulletin. It also provides the national accreditation program for mammography. ACR also hosts the ACR career center for radiologists. The College was founded in 1923 and its office is located in Reston, VA. | Corporate Officer/Principal | - |
American College of Cardiology Foundation
 American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Eluminex Biosciences Ltd.
 Eluminex Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Eluminex Biosciences Ltd. is a Chinese clinical-stage biotechnology company that focuses on the development and commercialization of innovative therapeutics for ophthalmic diseases. Eluminex's headquarters and research and development center are located in Biobay Industrial Park, with a US-subsidiary located in the area. The private company has developed a pipeline of next-generation protein therapeutics for retinal diseases, including age-related macular degeneration, macular edema, and diabetic retinopathy. The company is devoted to innovating the next generation of first-in-class or ocular therapeutics for vision-threatening or lifestyle-limiting ocular diseases. Eluminex has exclusively licensed rights for the development and commercialization of an investigational clinical-stage biosynthetic cornea derived from recombinant human collagen type III for the treatment of corneal blindness. | Directeur Technique/Scientifique/R&D | 01/06/2020 |
Anciens postes connus de Charles Semba
| Sociétés | Poste | Fin |
|---|---|---|
| CALCIMEDICA, INC. | Directeur Technique/Scientifique/R&D | 01/03/2020 |
ForSight VISION5, Inc.
 ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ. | Directeur Technique/Scientifique/R&D | 01/01/2016 |
| Stanford University School of Medicine | Corporate Officer/Principal | - |
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | President | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Charles Semba
| Carleton College | Undergraduate Degree |
| University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DIAMEDICA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Health Technology |
ForSight VISION5, Inc.
ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ. | Electronic Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
The American College of Radiology
The American College of Radiology Miscellaneous Commercial ServicesCommercial Services The American College of Radiology is a national organization serving radiologists, radiation oncologists, interventional radiologists, and medical physicists with programs focusing on the practice of radiology and the delivery of comprehensive health care services. ACR devotes its programs to make imaging safe, effective, and accessible. The college publishes the journal of the American College of Radiology and the ACR bulletin. It also provides the national accreditation program for mammography. ACR also hosts the ACR career center for radiologists. The College was founded in 1923 and its office is located in Reston, VA. | Commercial Services |
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Health Services |
Eluminex Biosciences Ltd.
Eluminex Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Eluminex Biosciences Ltd. is a Chinese clinical-stage biotechnology company that focuses on the development and commercialization of innovative therapeutics for ophthalmic diseases. Eluminex's headquarters and research and development center are located in Biobay Industrial Park, with a US-subsidiary located in the area. The private company has developed a pipeline of next-generation protein therapeutics for retinal diseases, including age-related macular degeneration, macular edema, and diabetic retinopathy. The company is devoted to innovating the next generation of first-in-class or ocular therapeutics for vision-threatening or lifestyle-limiting ocular diseases. Eluminex has exclusively licensed rights for the development and commercialization of an investigational clinical-stage biosynthetic cornea derived from recombinant human collagen type III for the treatment of corneal blindness. | Health Technology |
